Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to assess the potential effectiveness of Cosentyx in the treatment of adult-onset Pityriasis Rubra Pilaris or PRP.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03342573
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase Phase 1
Start date April 1, 2018
Completion date February 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT03975153 - Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP) Phase 2
Completed NCT03485976 - Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP) Phase 2
Not yet recruiting NCT06444399 - Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris Phase 2
Terminated NCT00815633 - A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris Phase 4